Related Experiment Videos
Oxidation of glucosamine by human polymorphonuclear leukocytes
Inflammation
|March 1, 1981
Summary
Human polymorphonuclear leukocytes (PMNs) metabolize glucosamine via the hexosemonophosphate shunt (HMPS), but require intact cells and possibly a cofactor for this process, differing from glucose metabolism.
Area of Science:
- Cellular metabolism
- Immunology
- Biochemistry
Background:
- Human polymorphonuclear leukocytes (PMNs) are key immune cells involved in phagocytosis.
- Understanding the metabolic pathways utilized by PMNs during activation is crucial for immune response research.
Purpose of the Study:
- To investigate the metabolic fate of glucosamine in human PMNs upon stimulation.
- To compare the oxidative pathways of glucosamine and glucose in PMNs.
Main Methods:
- Incubation of human PMNs with opsonized zymosan to induce phagocytosis.
- Measurement of 14CO2 production from [1-14C]glucosamine and [1-14C]glucose.
- Assessment of the role of the hexosemonophosphate shunt (HMPS) and specific enzymes like glucose-6-phosphate dehydrogenase.
Main Results:
- PMNs produced CO2 from glucosamine at 10-25% the rate of glucose, indicating glucosamine utilization.
- Glucosamine oxidation was dependent on HMPS activation and inhibited by glucose, suggesting pathway overlap.
- Key HMPS enzyme glucose-6-phosphate dehydrogenase did not act on glucosamine-6-phosphate, and sonically disrupted PMNs failed to oxidize glucosamine, indicating a requirement for intact cells.
Conclusions:
- PMNs likely convert glucosamine into a substrate compatible with HMPS enzymes for oxidation.
- This conversion process requires intact PMNs and potentially an unidentified cofactor.
- The metabolic pathway for glucosamine oxidation in PMNs differs from that of glucose.